DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
申请人:ARDEA BIOSCIENCES, INC.
公开号:US20170183333A1
公开(公告)日:2017-06-29
This invention concerns N-(2-arylamino) aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.